In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates

Diagnostic Microbiology and Infectious Disease

Volumn 77, Issue 3, 2013, Pages 254-257

  Tang, Hung Jen ^a,b   Chen, Chi Chung ^a,c   Zhang, Chun Cheng ^a   Su, Bo An ^a   Li, Chien Ming ^a   Weng, Tzu Chieh ^a   Chiang, Shyh Ren ^a   Ko, Wen Chien ^d   Chuang, Yin Ching ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Biofilm; Synergistic effect; Vancomycin resistant enterococci

Indexed keywords

AMPICILLIN; FOSFOMYCIN; LINEZOLID; MINOCYCLINE; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL LOAD; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENOTYPE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

BIOFILM; SYNERGISTIC EFFECT; VANCOMYCIN-RESISTANT ENTEROCOCCI;

ANTI-BACTERIAL AGENTS; DRUG SYNERGISM; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FOSFOMYCIN; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; VANCOMYCIN RESISTANCE;

EID: 84885372639     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.07.012     Document Type: Article

References (15)

1. Birmingham M.C., Rayner C.R., Meagher A.K., Flavin S.M., Batts D.H., Schentag J.J. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis 2003, 36:159-168.
2. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement (M100-S22). Wayne: CLSI; 2012.
3. Mohamed J.A., Huang D.B. Biofilm formation by enterococci. J Med Microbiol 2007, 56:1581-1588.
4. NCCLS. Methods for determining bactericidal activity of antimicrobial agents; approved guideline, NCCLS document M26-A. National Committee for Clinical Laboratory Standards, Wayne; 1999.
5. O'Neill E., Pozzi C., Houston P., Smyth D., Humphreys H., Robinson D.A., O'Gara J.P. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol 2007, 45:1379-1388.
6. Perri M.B., Hershberger E., Ionescu M., Lauter C., Zervos M.J. In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin. Diagn Microbiol Infect Dis 2002, 42:269-271.
7. Popovic M., Steinort D., Pillai S., Joukhadar C. Fosfomycin: an old, new friend?. Eur J Clin Microbiol Infect Dis 2010, 29:127-142.
8. Ramadhan A.A., Hegedus E. Biofilm formation and esp gene carriage in enterococci. J Clin Pathol 2005, 58:685-686.
9. Sandoe J.A., Witherden I.R., Au-Yeung H.K., Kite P., Kerr K.G., Wilcox M.H. Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases. J Antimicrob Chemother 2002, 50:577-582.
10. Sandoe J.A., Witherden I.R., Cove J.H., Heritage J., Wilcox M.H. Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo. J Med Microbiol 2003, 52:547-550.
11. Schulte B., Heininger A., Autenrieth I.B., Wolz C. Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium. Epidemiol Infect 2008, 136:1131-1133.
12. Shrestha N.K., Chua J.D., Tuohy M.J., Wilson D.A., Procop G.W., Longworth D.L., et al. Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin. Scand J Infect Dis 2003, 35:12-14.
13. Tang H.J., Chen C.C., Cheng K.C., et al. In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms. J Antimicrob Chemother 2012, 67:944-950.
14. Tenover F.C., Arbeit R.D., Mickelsen R.V., Goering P.A., Murray B.E., Persing D.H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
15. Wang J.L., Hsueh P.R. Therapeutic options for infections due to vancomycin-resistant enterococci. Expert Opin Pharmacother 2009, 10:785-796.